1. Home
  2. Analysis
  3. Rifampin
  4. Revatio

Rifampin and Revatio drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rifampin and Revatio. Common interactions include faeces discoloured among females and nasal obstruction among males.

The phase IV clinical study analyzes what interactions people who take Rifampin and Revatio have. It is created by eHealthMe based on reports of 9 people who take Rifampin and Revatio from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 30, 2022

9 people who take Rifampin and Revatio together, and have interactions are studied.

What is Rifampin?

Rifampin has active ingredients of rifampin. It is often used in tuberculosis. eHealthMe is studying from 8,527 Rifampin users for its effectiveness, alternative drugs and more.

What is Revatio?

Revatio has active ingredients of sildenafil citrate. It is often used in pulmonary hypertension. eHealthMe is studying from 43,589 Revatio users for its effectiveness, alternative drugs and more.

Number of Rifampin and Revatio reports submitted per year:

Rifampin and Revatio drug interactions.

Common Rifampin and Revatio drug interactions by gender *:

female:

  1. Faeces discoloured
  2. Fall
  3. International normalised ratio increased
  4. Loss of consciousness
  5. Malaise
  6. Pneumonia
  7. Pyrexia
  8. Respiratory arrest
  9. Rheumatoid arthritis
  10. Swelling

male:

  1. Nasal obstruction
  2. Cough
  3. Drug hypersensitivity
  4. Hypersensitivity
  5. Pyrexia
  6. White blood cell count decreased

Common Rifampin and Revatio drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Amnesia
  2. Blood potassium decreased
  3. Cellulitis
  4. Diarrhoea
  5. Faeces discoloured
  6. Fall
  7. Laceration
  8. Loss of consciousness
  9. Malaise
  10. Pneumonia

40-49:

  1. Blood potassium decreased
  2. Cardiac failure
  3. Cardiac failure chronic
  4. Cellulitis
  5. Confusional state
  6. Cough
  7. Diarrhoea
  8. Dyspnoea
  9. Dyspnoea exertional
  10. Faeces discoloured

50-59:

  1. Anaemia
  2. Gastrointestinal haemorrhage
  3. Hypersensitivity
  4. Hypotension
  5. International normalised ratio increased

60+:

  1. Cough
  2. Pyrexia
  3. White blood cell count decreased

* Approximation only. Some reports may have incomplete information.

Do you take Rifampin and Revatio?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Rifampin and Revatio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Rifampin side effects:

Browse all side effects of Rifampin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Revatio side effects:

Browse all side effects of Revatio:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Rifampin interactions:

Browse all interactions between Rifampin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Revatio interactions:

Browse all interactions between Revatio and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on rifampin and sildenafil citrate (the active ingredients of Rifampin and Revatio, respectively), and Rifampin and Revatio (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Rifampin and Revatio.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.